Login: Private Area
Forgot password?
CINP 2008 Infobox
• Psychopharmacology
• CNS disorders
• Neurological disorders
• Mental disorders
Satellite and Luncheon Satellite Symposia | |||
| Date | Time | Company / Titel | Hall |
| Sunday, 13 July 2008 | 14.00-15.30 h | Eli Lilly and Company "Changing paradigms in the long-term treatment of schizophrenia" | Hall 1 |
| 16.00-17.30 h | Servier "The melatonergic approach: A breakthrough in the management of depressed patients" | Hall 1 | |
| Monday, 14 July 2008 | 12.15-13.45 h | GlaxoSmithKline "Advancing insomnia therapy: Circuitry, pharmacology, and co-morbidity" | Hall 5 |
| 12.15-13.45 h | Bristol-Myers Squibb and Otsuka Pharmaceuticals "Bipolar Disorder: From Theory to Practice" | Hall 13a | |
| 12.15-13.45 h | Janssen Cilag Romania "Remission, Therapeutic Compliance and Quality of Life in Long Term Treatment of Schizophrenia" | Hall 1 | |
| 18.00-19.30 h | Organon, a part of Schering-Plough Corporation "New Perspectives in Antipsychotic Therapy" | Hall 1 | |
| 18.00-19.30 h |
| Hall 4 | |
| Tuesday, 15 July 2008 | 12.15-13.45 h | Janssen Cilag "Long Term Management of Bipolar Disorder" | Hall 1 |
| 12.15-13.45 h | Wyeth Pharmaceuticals "Diagnosis and Treatment Dilemmas in Major Depressive Disorder: Narrowing the Gap" | Hall 5 | |
| 12.15-13.45 h | Pfizer "Winning Hearts and Minds—Choices in Antipsychotic Therapy" | Hall 13a/b | |
| 18.00-19.30 h | Lilly Deutschland GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG "General anxiety disorders - Challenges and therapeutic approaches" | Hall 1 | |
| 18.00-19.30 h | AstraZeneca GmbH "Mood symptoms across the spectrum of psychiatric illness" | Hall 5 | |
| 18.00-19.30 h | Solvay Pharmaceuticals GmbH "New Developments on Sigma-1 Receptors and Clinical Implications in the Treatment of Depression" | Hall 13a | |
| Wednesday, 16 July 2008 | 12.15-13.45 h | AstraZeneca UK "The role of dopamine and noradrenaline in antipsychotic drug treatment" | Hall 5 |